NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

Download a CSV of all Patent records.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset Search to show all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCI E-082-2004-1-US-01 Methods Of Preventing Or Treating T Cell Malignancies By Adminstering CD2 Antagonists US 60/410,385 Abandoned
NCI E-320-2005-0-US-01 Transduced Neoplastic Cell Preparations Able To Express T-cell Costimulatory Molecules B7.1, ICAM-1, And LFA-3 And Induce Immunostimulatory Prophlactic And Therapeutic Anti-tumor Effects In-vivo US 60/410,161 Abandoned
NIAID E-286-2002-0-US-01 Aerosolized Capreomycin for Inhibition of Pulmonary Tuberculosis US 60/410,601 Abandoned
NHLBI E-223-2002-0-US-01 FACTORS THAT BIND INTESTNAL TOXINS US 60/409,742 Abandoned
NEI E-304-2003-0-US-01 CONTAINER FOR DRYING BIOLOGICAL SAMPLES, METHODS OF MAKING SUCH CONTAINER, AND METHOD OF USING SAME. US ORD 10/238,147 Abandoned
NIAAA E-041-2000-0-US-04 METHODS AND COMPOUNDS FOR INHIBITING CALPAINS US CON 10/238,978 Abandoned
NCI E-275-2002-0-US-01 Immunotherapy With in Vitro Selected Antigen-Specific Lymphocytes After Nonmyeloablative Lymphodepleting Chemotherapy US 60/408,681 Abandoned
NCI E-035-2002-0-US-01 Backbone Substituted Bifunctional DOTA Ligands And Complexes thereofmbk US 60/408,676 Abandoned
NIDCR E-295-2001-0-PCT-02 Imaging The Activity of Extracellular Proteases In Cells Using Mutant Anthax Toxin Protective Antigens That Are Cleaved By Specific Extracellular Proteases. PCT PCT PCT/US02/028397 Expired
NCI E-239-2002-0-US-01 Minimally Immunogenic Variant of Humanized COL-I Antibody Against Carcinoembryonic Antigen (CEA) US 60/408,703 Abandoned
NCI E-082-2004-0-US-01 Methods of Preventing or Treating T Cell Malignancies by Administering CD2 Antagonists US 60/409,024 Abandoned
NCI E-245-2002-0-US-01 AKT INHIBITORS, PHARMACEUTICAL COMPOSITIONS, AND USES THEREOF US 60/407,239 Abandoned
NCI E-064-2001-0-US-02 Measurements of Multiple RNA, Proteins And Antibody Binding Using CryoArray US ORD 10/233,193 6951761 Expired PDF
NCI E-064-2001-0-PCT-03 MEASUREMENTS OF MULTIPLE MOLECULES USING A CRYOARRAY PCT PCT PCT/US2002/027955 Expired
NIMH E-247-2001-0-PCT-02 Effect of BDNF Genotype on verbal Memory And Risk For Schizophrenia PCT PCT PCT/US02/28086 Expired
NCI E-236-2001-0-PCT-02 New Adenovirus Type 7 Vectors PCT PCT PCT/US2002/027592 Expired
NCI E-335-2001-0-PCT-02 Methods of Generating Human CD4+ TH1 Cells PCT PCT PCT/US02/27824 Expired
NCI E-151-2002-0-PCT-02 METHODS FOR FUNCTIONAL KIDNEY IMAGING USING SMALL DENDRIMER CONTRAST AGENTS PCT PCT PCT/US02/027297 Expired
NCI E-151-2002-0-EP-04 METHODS FOR FUNCTIONAL KIDNEY IMAGING USING SMALL DENDRIMER CONTRAST AGENTS EP National Stage 02770437.8 Abandoned
NCI E-151-2002-0-CA-03 METHODS FOR FUNCTIONAL KIDNEY IMAGING USING SMALL DENDRIMER CONTRAST AGENTS CA National Stage 2496802 Abandoned
NHLBI E-003-2000-0-US-03 Regulators of Type-1 Tumor Necrosis Factor Receptor and Other Cytokine Receptor Shedding US National Stage 10/220,443 7135303 Abandoned PDF
CC E-278-1999-0-US-04 Multiplex Hybridization System For The Identification Of Pathogenic Mycobacterium And Method Of Use US National Stage 10/220,212 7271781 Abandoned PDF
NCI E-151-2002-0-US-01 METHODS FOR FUNCTIONAL KIDNEY IMAGING USING SMALL DENDRIMER CONTRAST AGENTS US ORD 10/229,316 6852842 Abandoned PDF
NIDCR E-320-2001-0-AU-06 METHODS OF INHIBITING FORMATION OF VASCULAR CHANNELS AND METHODS OF INHIBITING PROLIFERATION AU National Stage 2002323368 Abandoned
NCI E-150-2001-1-US-01 Use of a Promotor of T-Cell Expansion And an Inducer of CD40 Stimulation in The Treatment or Prevention of a Pathologic State US ORD 10/226,959 7175838 Abandoned PDF
NCI E-290-2000-0-JP-07 Detection And Quantification of Cripto-1 JP National Stage 2002-559686 Abandoned
NIDDK E-242-2001-0-PCT-02 FOLDED MONOMERS OF THE HIV-1 PROTEASE AND METHODS OF THEIR USE PCT PCT PCT/US02/26757 Abandoned
NCI E-198-2001-0-PCT-02 Use of a Histone Deacetylase Inhibitor to Increase The Entry of an Adenoviral Agent Into a Cell PCT PCT PCT/US02/26908 Expired
NIDCR E-320-2001-0-EP-04 METHODS OF INHIBITING FORMATION OF VASCULAR CHANNELS AND METHODS OF INHIBITING PROLIFERATION EP National Stage 02757347.6 Abandoned
NIDCR E-320-2001-0-CA-05 METHODS OF INHIBITING FORMATION OF VASCULAR CHANNELS AND METHODS OF INHIBITING PROLIFERATION CA National Stage 2456269 Abandoned
NCI E-086-2001-1-PCT-01 PEPTIDES OF A MELANOMA ANTIGEN AND THEIR USE IN DIAGNOSTIC, PROPHYLACTIC AND THERAPEUTIC METHODS PCT PCT COMB PCT/US2002/026957 Expired
NCI E-273-2002-0-US-01 NITROXYL PROGENITORS IN THE TREATMENT OF HEART FAILURE US ORD 10/226,412 6936639 Expired PDF
NCI E-284-2002-0-US-01 Universal Detector and Adaptor for Microelectric Nanochip SNP Detection US 60/404,777 Abandoned
NCI E-304-2000-0-US-01 ABCA13 Nucleic Acids and Proteins, and Uses Thereof US 60/405,006 Abandoned
NCI E-277-2002-1-US-01 Methods, Compositions and Systems for the Identification and Characterization of Cytochrome bc1 Inhibitors US 60/404,146 Abandoned
NINDS E-303-2001-0-US-01 Method for Production of Human Insulin Producing Cells US 60/404,578 Abandoned
NIDDK E-222-2002-0-US-01 A Method of Inducing Differentiation By Inhibiting Proliferation of Precursor/Progenitor Cells and of Treating Diabetes by Cell... US 60/404,577 Abandoned
NCI E-173-2001-0-US-01 HTLV-1 p30II AND p12 PROTEINS AS THERAPEUTIC TARGETS IN HTLC-1 INFECTED INDIVIDUALS US 60/404,580 Abandoned
NCI E-317-2002-0-EP-04 Molecular Characteristics of Non-Small Cell Lung Cancer EP National Stage 02794901.5 Expired
NCI E-200-1990-4-HK-09 GENERATION OF IMMUNE RESPONSES TO PROSTATE-SPECIFIC ANTIGEN (PSA) HK National Stage 02103565.7 Expired
NCI E-317-2002-0-PCT-02 Molecular Characteristics of Non-Small Cell Lung Cancer PCT PCT PCT/US2002/026027 Expired
NINDS E-092-1993-1-US-04 CELL TESTS FOR ALZHEIMER'S DISEASE US CON 10/222,344 Abandoned
NCI E-317-2002-0-JP-05 Molecular Characteristics of Non-Small Cell Lung Cancer JP National Stage 2003-520378 Expired
NCI E-317-2002-0-CA-06 Molecular Characteristics of Non-Small Cell Lung Cancer CA National Stage 2456334 Abandoned
NCI E-342-2003-0-US-01 Hepatitis C Viral-Like Particle Purification US 60/404,183 Abandoned
CC E-248-2001-0-US-01 Apparatus for Multifocal Deposition and Analysis and Methods for its Use US 60/403,875 Abandoned
NIAAA E-321-2001-0-PCT-02 Novel Vasoconstrictor Cannabinoid Analogs PCT PCT PCT/US02/26050 Expired
NHLBI E-325-2001-1-US-01 Production of Adeno-Associated Virus in Insect Cells US CIP 10/216,870 6723551 Expired PDF
NIDDK E-323-2002-2-US-01 Novel Combination Therapy to Treat Glaucoma US CIP 10/217,755 Abandoned
NIEHS E-129-2004-0-PCT-03 Thermostable UvrA, UvrB, Adn UvrC Polypeptides And Methods Of Use PCT PCT PCT/US02/25567 Expired